Boulder Care is a technology company.
Boulder Care has raised $81.0M across 3 funding rounds.
Boulder Care has raised $81.0M in total across 3 funding rounds.
Boulder Care has raised $81.0M in total across 3 funding rounds.
Boulder Care's investors include David Ibnale, Advance Venture Partners, First Round Capital, Laerdal Million Lives Fund, Stripes Group, Telescope Partners, Tusk Venture Partners, Coatue, Daffy, Fenway Summer, Indeed.com, Tiffany Luck.
Boulder Care is a Portland, Oregon-based telehealth company founded in 2017 that provides evidence-based treatment for substance use disorders (SUD), including opioid use disorder (OUD) and alcohol use disorder (AUD).[1][2][3] It serves patients nationwide through a secure mobile app, offering comprehensive outpatient care with medications for addiction treatment (MAT) like Suboxone, clinician support, peer recovery coaching from specialists with lived experience, and care navigation—all grounded in kindness and unconditional support to improve health outcomes, retention, and costs via value-based payments.[1][2][3] The company targets individuals lacking access to specialists (over 70% of the U.S.), employers, health plans, and clinicians, addressing systemic issues like stigma, misinformation, and low-quality care; it has raised over $50M in funding (including a $36M Series B in 2022), grown to 232 employees by mid-2025, doubled patients recently, and earned accolades like Fast Company's Most Innovative Company (2021) and Inc.'s fastest-growing firms (2024).[1][2][4][5]
Boulder Care was founded in 2017 in Brooklyn, NY, by CEO Stephanie Strong, who launched it as an app-based telehealth program to deliver accessible addiction treatment amid widespread gaps in specialist care.[1][2][4] Strong's vision emerged from recognizing systemic flaws in addiction treatment—lack of evidence-based options, stigma-driven poor experiences, and misaligned incentives favoring costly, low-quality services—prompting a model blending medical, behavioral, and psychosocial support.[1] Early traction included partnerships with national health plans and employers, recognition as Fast Company's Most Innovative Company in Health (2021), and funding from investors like First Round and Greycroft; by 2022, a $36M Series B fueled expansion, followed by adolescent programs, state growth, and a 30% headcount increase since early 2025.[1][2][4]
Boulder Care rides the telehealth boom in behavioral health, capitalizing on post-pandemic demand for virtual SUD treatment amid America's opioid crisis and rising alcohol use, where over 70% lack specialist access.[1][3] Timing aligns with regulatory shifts enabling MAT prescriptions via telehealth, insurance expansions, and value-based care trends favoring outcomes over volume—positioning Boulder to disrupt fragmented, stigma-laden addiction services.[1][2] Market forces like digital health maturation (emulating Teladoc/Livongo) and employer focus on employee wellness amplify its reach, while its peer-led model influences the ecosystem by normalizing lived-experience integration and proving telehealth's efficacy for high-need, vulnerable populations.[3][4]
Boulder Care is poised for accelerated growth in 2025 and beyond, targeting new states, service expansions (e.g., more adolescent programs), and deeper health plan penetration amid optimistic leadership on impact.[4] Trends like AI-enhanced care coordination, broader MAT access, and digital health consolidation will shape its path, potentially elevating it to Teladoc-scale via proven retention and cost savings. Its influence may evolve by setting standards for compassionate, tech-enabled SUD care, humanizing treatment in a resilient telehealth landscape started with accessible innovation.[1][4]
Boulder Care has raised $81.0M across 3 funding rounds. Most recently, it raised $35.0M Series C in May 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2024 | $35.0M Series C | David Ibnale, Advance Venture Partners, First Round Capital, Laerdal Million Lives Fund, Stripes Group, Telescope Partners, Tusk Venture Partners | |
| Jun 1, 2022 | $36.0M Series B | Coatue, Daffy, Fenway Summer, First Round Capital, Indeed.com, Tiffany Luck, Pareto Holdings, Greg Bettinelli, Vera Equity, Amit Agarwal, Gokul Rajaram, Jacqueline Reses, Jeffrey Wald, Shishir Mehrotra, Tony Xu | |
| Jan 1, 2020 | $10.0M Series A | Coatue, Daffy, Fenway Summer, First Round Capital, Goodwater Capital, Indeed.com, Tiffany Luck, Pareto Holdings, Red Swan Ventures, RRE Ventures, Greg Bettinelli, Tusk Venture Partners, Vera Equity, Amit Agarwal, Gokul Rajaram, Jacqueline Reses, Jeffrey Wald, Shishir Mehrotra, Steve Schlafman, Tony Xu |